Skip to content

Insider · CIK 0001786003

Fishman Mark

Reports to the SEC for 1 company · CAMBRIDGE, MA

Transactions

9

Companies

1

Filings

7

CIK

0001786003

Forms 4 and 5

Insider transactions

9 trades
DateCompanyValue
2026-06-03BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2025-06-04BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2024-06-05BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2023-06-06BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2022-09-01BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2021-06-10BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award—
2020-02-10BEAMBeam Therapeutics Inc.C Conversion—
2020-02-10BEAMBeam Therapeutics Inc. · Series A-1 Preferred StockC Conversion—
2020-02-10BEAMBeam Therapeutics Inc. · Series A-2 Preferred StockC Conversion—

Recent filings

7

Companies

1

Address

C/O BEAM THERAPEUTICS INC., 238 MAIN STREET

CAMBRIDGE, MA, 02142